WHO ICTRP trial
NicoNovum Evaluation of Withdrawal Relief Study Part 2
ACTRN12607000086460 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12607000086460 |
|---|---|
| Public title | NicoNovum Evaluation of Withdrawal Relief Study Part 2 |
| Scientific title | A phase III, single blind, randomised, cross-over trial of the effects of a novel nicotine replacement therapy (NicoNovum mouthspray and lozenge)in the treatment of withdrawal relief in smokers. |
| Primary sponsor | Professor Peter Hajek |
| Secondary sponsors | Dr Hayden McRobbie |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | New Zealand |
| Conditions | Smokers; Smokers;Public Health - Health service research;Mental Health - Addiction |
| Interventions | Niconovum nicotine mouthspray (1mg/spray - 3 spray dose). Mode of administration: Spray between cheek and gum. Niconovum nicotine lozenge (2.5mg). Mode of administration: dissolve in mouth - do not chew. This trial has a crossover design… |
| Registration date | Jan 25, 2007 |
| Target size | 52 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: